import { config } from 'dotenv';
config({ path: '.env.local' });

import { drizzle } from 'drizzle-orm/neon-http';
import { neon } from '@neondatabase/serverless';
import { posts } from './schema';

const sql = neon(process.env.DATABASE_URL!);
const db = drizzle({ client: sql });

const post = {
  title: 'Oracle Clinical vs. Medidata Rave vs. Veeva Vault CDMS: User Processes, Data Models, and Market Position',
  slug: 'oracle-clinical-medidata-rave-veeva-vault-cdms-comparison',
  excerpt:
    'A technical and operational comparison of the three dominant clinical data management systems used in pharma and biotech trials: Oracle Clinical, Medidata Rave EDC, and Veeva Vault CDMS — covering user workflow, database schema design, and market positioning.',
  category: 'pharma-clinical-trials' as const,
  published: true,
  isPremium: false,
  publishedAt: new Date('2026-06-20'),
  youtubeUrl: null,
  content: `Clinical Data Management Systems (CDMS) are the databases at the centre of every clinical trial. They capture, validate, query, and lock the patient data that regulatory agencies use to approve or reject new drugs and devices. Choosing the wrong platform — or failing to understand how it works technically — creates risk at data lock, delays submissions, and complicates regulatory inspections.

This post compares the three platforms most commonly encountered in mid-to-large pharma and biotech trials: **Oracle Clinical** (the established on-premises product), **Medidata Rave EDC** (the long-standing SaaS market leader), and **Veeva Vault CDMS** (the fastest-growing cloud challenger). The comparison covers user workflows, data model architecture, and where each platform stands in the current market.

---

## Background: What a CDMS Must Do

Every clinical trial CDMS must support the same core lifecycle regardless of vendor:

1. **Study build** — define the protocol structure, visit schedule, and electronic case report form (eCRF) pages
2. **Site activation** — provision investigator sites and user accounts
3. **Subject enrollment and data entry** — capture patient observations against the protocol schedule
4. **Edit check execution** — run programmatic validation rules to identify protocol deviations and data inconsistencies
5. **Discrepancy management** — issue queries to sites, track responses, and resolve data questions
6. **Medical coding** — map adverse events and medications to standard dictionaries (MedDRA, WHODrug)
7. **Database lock** — freeze the dataset for statistical analysis
8. **Regulatory export** — produce CDISC-compliant datasets (SDTM, ADaM) for submission

The differences between platforms are in how each layer is implemented, who controls the database, and how tightly the system integrates with adjacent clinical operations tools.

---

## Oracle Clinical

### Background

Oracle Clinical (OC) is Oracle's legacy on-premises CDMS, originally developed in the 1990s and still in active use at large pharmaceutical companies that built their data management operations around it. It runs on an Oracle Database instance managed by the sponsor or CRO, giving the data management team direct SQL access to all captured data. Oracle has since launched Clinical One as a cloud-native successor, but Oracle Clinical remains installed at a significant number of enterprise accounts.

### User Processes

**Study build** is performed in Oracle Clinical Studio, a thick-client design tool. The study administrator defines the Data Collection Instrument (DCI) — the container that maps to a visit — and the Data Collection Modules (DCMs) within it, which correspond to CRF sections. Each DCM contains questions (variables) with response validation rules and derivation scripts written in PL/SQL. Study build is technically demanding: the design is stored directly in the relational database and any structural change after live data entry requires a schema amendment procedure with impact analysis.

**Data entry** at investigator sites is performed through Remote Data Capture (RDC), a web-based interface that presents eCRF pages for patient visits. Sites enter data visit by visit. Each save triggers synchronous server-side PL/SQL validation. Discrepancies appear inline and are tracked in the DCM response record.

**Discrepancy management** is handled through the OC Discrepancy Management module. A discrepancy is a database row in the \`RDC_DISCREPANCIES\` table linked to the specific data point and DCM response. Clinical data managers (CDMs) review open discrepancies through the OC interface or directly via SQL and route them to sites as queries.

**Database lock** is a formal procedure: the DBA runs a series of validation queries to confirm no open discrepancies, no missing visits, and no pending derivations, then sets a lock status flag at the study level. Post-lock changes require an unblind procedure with documented justification.

### Database Schema

Oracle Clinical stores all data in the Oracle Database schema of the \`CLINICAL\` or custom schema user. Key table families:

| Table / Object | Content |
|----------------|---------|
| \`OCL_STUDIES\` | Study master record, status, protocol version |
| \`OCL_PATIENTS\` | Subject (patient) enrollment records per site |
| \`DCM_SUBSET_ITEMS\` | Defines the questions (variables) within each DCM |
| \`RDC_RESPONSES\` | The core fact table — one row per question per visit per patient |
| \`RDC_DISCREPANCIES\` | Open and resolved discrepancies (queries) linked to response rows |
| \`AUDIT_INFO\` | Audit trail entries; complies with 21 CFR Part 11 electronic records requirements |
| \`OC_DERIVATIONS\` | PL/SQL derivation rule definitions for calculated fields |

The schema is deeply relational and tightly coupled. Joins across \`RDC_RESPONSES\`, \`DCM_SUBSET_ITEMS\`, and \`OCL_PATIENTS\` are the standard pattern for any data extraction. The PL/SQL validation engine runs inside the database, which means a DBA who understands Oracle execution plans can diagnose validation performance problems directly from AWR and SQL Monitor.

**Strengths of the OC data model**: full SQL access, mature audit trail, tight integration with Oracle's broader data management toolset (Oracle Data Integrator for SDTM derivation pipelines, Oracle Reports for in-database listings).

**Weaknesses**: schema changes are slow and risky; multi-tenancy is managed by schema separation rather than by application design; no native CDISC ODM import/export without custom ETL.

---

## Medidata Rave EDC

### Background

Medidata Rave (now branded Rave EDC) is a cloud-based, multi-tenant SaaS platform. It is the most widely deployed EDC system in the industry, used across a large proportion of Phase II–III oncology and rare disease trials globally. Medidata was acquired by Dassault Systèmes in 2019. The platform integrates with Medidata's broader clinical trial suite (Rave Safety, Rave Payments, Rave Imaging) through the iMedidata unified login layer.

Customers do not have access to the Rave database schema. All data access is through the Rave web application, the Rave EDC API (REST), or the Rave Extract (scheduled dataset export).

### User Processes

**Study build** is performed in Rave Architect, a browser-based design tool. The designer creates a Study with a hierarchy of Folders (visits), Forms (CRF sections), and Fields (data points). Edit checks are written in Rave's proprietary OpenRules language or in the extended Medidata Rules language, which supports conditional logic, cross-form derivations, and auto-queries. Studies can be templatized and versioned; amendments are managed through a Draft → Published → Active release cycle with controlled amendment propagation to live subjects.

**Data entry** is performed by site staff in the Rave web interface. The interface is responsive and subject-centric: a site user opens a subject record, selects the visit folder, and enters form data. Auto-queries fire immediately on save. Manual queries can be issued by the sponsor's data management team against specific data points.

**Discrepancy management** in Rave uses a Query workflow: Open → Answered → Closed. Queries are tied to specific Fields within specific Form instances. Data managers review the query listing across the study or by site, and can mark answers as accepted (closing the query) or rejected (re-opening). The full query history is stored in the audit trail.

**Medical coding** is performed in Rave Coder, a module embedded in the platform that presents verbatim terms to coders alongside a suggested dictionary match. Coders accept or override suggestions; the coded term is written back to the subject record.

**Database lock** is managed through Rave's Lock subject workflow. Each subject passes through a defined sequence: data review complete → signature (if configured) → lock. Locked subjects are immutable through the UI. Post-lock corrections require an unlock with documented reason and re-lock, both captured in the audit trail.

### Data Model (Logical)

Rave's internal schema is proprietary and multi-tenant, but the logical data hierarchy is well-documented through the API:

\`\`\`
Study
  └── Site (investigator location + country)
        └── Subject (patient enrollment record)
              └── Folder (visit instance; repeating or fixed)
                    └── Form (CRF section instance)
                          └── Field (data point)
                                └── DataPoint (current value + audit history)
\`\`\`

Each DataPoint has a full audit history — every value change is recorded with user, timestamp, and reason. This structure maps cleanly to the CDISC ODM data model (StudyEventRef, FormRef, ItemGroupRef, ItemRef) and exports natively to ODM XML.

**Key API entities** (from the Rave REST API):

| Entity | Description |
|--------|-------------|
| \`StudyVersion\` | Protocol-specific metadata: folders, forms, fields, edit check definitions |
| \`Subject\` | Patient enrollment record with status (Active, Enrolled, Withdrawn, Completed) |
| \`FormData\` | Submitted form instance with all field values |
| \`Queries\` | Discrepancy records linked to specific data points |
| \`AuditRecords\` | Immutable audit trail entries for data changes |
| \`ReviewStatuses\` | SDV, DM review, and lock flags at the data-point level |

**Strengths of the Rave data model**: clean CDISC ODM alignment; versioned study metadata; rich review and lock state tracking at the data-point level; REST API enables programmatic extraction; built-in audit trail meets 21 CFR Part 11 and Annex 11 without customisation.

**Weaknesses**: no direct SQL access; all reporting depends on Rave extract files or API; cross-study analytics require Medidata's separate AI/analytics platform; study build complexity for non-standard designs requires specialist Rave architect skills.

---

## Veeva Vault CDMS

### Background

Veeva Vault CDMS (also called Vault EDC) launched in 2019 as part of the Veeva Vault clinical suite. It is built on the Vault platform — Veeva's document and data management system that also powers Vault eTMF (trial master file), Vault ePRO (patient-reported outcomes), Vault Safety (pharmacovigilance), and Vault Clinical Data Management (supporting data manager workflows). The unified platform is Veeva's primary differentiator: data captured in Vault EDC flows natively to Vault Safety, Vault eTMF, and ultimately to Vault submissions.

Like Rave, customers access Vault through a browser interface and a REST/GraphQL API. There is no direct database access.

### User Processes

**Study build** is performed in Vault CDMS Designer, a browser-based configuration tool. The designer creates a Study Definition with a hierarchy of Events (visits), Forms, and Items. Veeva uses CDISC CDASH as the default data collection standard, meaning forms are pre-structured around CDASH domains (AE, CM, EX, LB, VS, etc.) by default. Custom forms can be added. Edit checks (called Expressions in Vault) are written in a proprietary expression language with conditional branching and cross-form references.

**Data entry** at sites uses the Vault EDC subject entry interface. The layout is comparable to Rave: subject-centric navigation with visit folders and form sections. A notable difference is that Vault's form rendering uses the same document object model as other Vault products, meaning study forms look and behave consistently with other Vault documents that site staff may already use (e.g., eTMF documents, informed consent forms).

**Discrepancy management** follows a similar Query lifecycle to Rave: Open → Responded → Closed. A key integration advantage is that an adverse event entered in Vault EDC can trigger a direct workflow event in Vault Safety for expedited reporting, without a separate data transfer step.

**Database lock** in Vault uses a multi-stage Freeze/Lock workflow: Forms can be frozen at the site level, then locked at the study level. Frozen forms are read-only to sites but editable by the data management team. Locked forms are read-only to all users.

### Data Model (Logical)

Vault's underlying object model is generic (designed to hold any structured data or document), with clinical-specific extensions layered on top:

\`\`\`
Study Definition
  └── Event Schedule (visit plan)
        └── Event (visit instance for a subject)
              └── Form (data collection form instance)
                    └── Item Group (section within a form)
                          └── Item (individual data point)
                                └── Item Data (value + audit history)
\`\`\`

Vault stores data as Vault Objects (structured records) rather than relational rows. Each object type has defined fields, relationships to other object types, and lifecycle states. Clinical data objects map to standard CDISC domains:

| Vault Object Type | CDISC Equivalent | Content |
|-------------------|-----------------|---------|
| \`subject__v\` | DM (Demographics domain root) | Subject enrollment, status, randomisation |
| \`event__v\` | StudyEvent | Visit instance for a subject |
| \`form_data__v\` | FormData | Submitted form instance |
| \`item_data__v\` | ItemData | Individual field value with audit history |
| \`query__v\` | DataQuery | Discrepancy record linked to an item |
| \`coding_assignment__v\` | Supplemental | Medical coding result (MedDRA / WHODrug) |

Vault's object model supports native GraphQL queries through the Vault API, making cross-object data extraction more flexible than a fixed-schema relational extract.

**Strengths of the Vault data model**: CDASH-first design accelerates study build; native cross-cloud integration (EDC → Safety → eTMF) without ETL; consistent object model across the Vault platform simplifies regulatory inspection; GraphQL API for structured queries.

**Weaknesses**: newer platform means fewer battle-tested complex trial designs; non-Veeva integrations require Vault Connections configuration; customers heavily invested in Medidata's ecosystem face significant migration effort; the generic object model can be less intuitive for DBAs expecting a relational schema.

---

## Side-by-Side Comparison

### User Process Comparison

| Process step | Oracle Clinical | Medidata Rave | Veeva Vault CDMS |
|-------------|----------------|--------------|-----------------|
| Study build tool | Oracle Clinical Studio (thick client) | Rave Architect (browser) | Vault CDMS Designer (browser) |
| CRF design unit | DCM (Data Collection Module) | Form + Fields | Form + Items (CDASH domain) |
| Edit check language | PL/SQL stored procedures | OpenRules / Medidata Rules | Vault Expression language |
| Data entry interface | RDC OC (browser) | Rave EDC (browser) | Vault EDC (browser) |
| Discrepancy workflow | RDC_DISCREPANCIES table / OC UI | Query (Open → Answered → Closed) | Query (Open → Responded → Closed) |
| Medical coding | External tool (Oracle TMS or third-party) | Rave Coder (embedded) | Vault CDMS Coder (embedded) |
| Database lock | DBA-run PL/SQL lock procedure | Subject-level workflow in UI | Form Freeze + Study Lock workflow |
| SDTM derivation | ODI pipelines / SAS from SQL export | Rave Extract → SAS/R | Vault to submission via integrated pipeline |
| Regulatory audit trail | \`AUDIT_INFO\` table; Part 11 compliant | Immutable audit records per data point | Vault object audit trail; Part 11 / Annex 11 |

### Data Model Comparison

| Dimension | Oracle Clinical | Medidata Rave | Veeva Vault CDMS |
|-----------|----------------|--------------|-----------------|
| Architecture | On-premises relational (Oracle DB) | SaaS multi-tenant proprietary | SaaS multi-tenant object model |
| Direct DB access | Yes (SQL/SYS DBA access) | No (API + extract only) | No (API + GraphQL) |
| Subject hierarchy | Study → Site → Patient → DCM Response | Study → Site → Subject → Folder → Form → Field | Study → Site → Subject → Event → Form → Item |
| CDISC alignment | Manual mapping to SDTM via ETL | ODM-aligned; SDTM via Rave Extract | CDASH-native; ODM export supported |
| Schema change mechanism | Formal amendment with DBA involvement | Study amendment via Architect (versioned) | Study amendment with propagation control |
| Audit trail location | Database table; DBA-queryable | Embedded per data point; API-accessible | Vault object audit; API-accessible |
| Coding integration | Oracle TMS (separate product) | Rave Coder (built-in module) | Vault Coder (built-in) |
| Data extraction format | SQL / Oracle Data Pump / SAS via ODBC | Rave Datasets extract (SAS XPT / CSV) | Vault export / GraphQL API / SAS XPT |

### Market Position

| Dimension | Oracle Clinical | Medidata Rave | Veeva Vault CDMS |
|-----------|----------------|--------------|-----------------|
| Market maturity | Mature; declining new adoption | Dominant; high renewal rates | High-growth challenger |
| Primary customer profile | Large pharma with existing Oracle infrastructure | Global pharma, large CROs, oncology biotechs | Veeva-platform customers; mid-size pharma moving to cloud |
| Deployment model | On-premises (cloud via Oracle Clinical One) | Multi-tenant SaaS (AWS hosted) | Multi-tenant SaaS (AWS hosted) |
| Therapeutic area strength | General (all areas historically) | Oncology, rare disease, large global trials | Growing across all areas; strong eTMF integration |
| Regulatory acceptance | Established (FDA, EMA, PMDA familiarity) | Established (widest global regulatory acceptance) | Accepted; growing regulatory familiarity |
| Integration ecosystem | Oracle stack (ODI, EBS, OBI, TMS) | iMedidata suite; third-party via API | Veeva Vault suite; third-party via Vault Connections |
| Key strength | DBA control, SQL transparency, Oracle stack | Market depth, Rave expertise pool, proven at scale | Unified clinical platform, CDASH-native, modern architecture |
| Key challenge | Legacy architecture; migration pressure | Complexity for non-standard designs; cost | Newer product; less proven in complex multi-regional trials |
| Typical deal driver | Existing Oracle investment; Oracle TMS use | CRO preference; Medidata ecosystem; oncology trial history | Veeva platform consolidation; eTMF/Safety integration value |

---

## Which Platform for Which Scenario

**Choose Oracle Clinical** when the organisation already runs Oracle Clinical with a trained data management team, Oracle TMS for medical coding, and downstream SAS analysis pipelines from SQL extracts. The switching cost is high and the platform is still functional for straightforward trial designs. Oracle Clinical One is Oracle's answer for teams that want to modernise without leaving the Oracle ecosystem.

**Choose Medidata Rave** when running large global trials, particularly in oncology or rare disease, where the wide pool of Rave-trained data managers, CROs, and regulatory affairs professionals reduces execution risk. Rave's depth — Rave Safety, Rave Payments, Rave Imaging — becomes a differentiator for complex multi-component studies. The cost and vendor dependency are the trade-offs.

**Choose Veeva Vault CDMS** when the organisation is already using Vault eTMF or Vault Safety and wants a unified clinical data platform where an adverse event entered in EDC flows automatically into pharmacovigilance without a separate data transfer. The CDASH-native design environment accelerates study build for standard therapeutic areas. Evaluate carefully for highly complex designs or where the trial footprint requires CRO partners with limited Vault experience.

---

## Technical Decision Criteria for DBAs and Data Managers

If you are a DBA or technical data manager evaluating these platforms, the most consequential technical differences are:

1. **SQL access vs. API-only**: Oracle Clinical gives you direct database access — you can write audit queries, performance diagnostics, and data listings in SQL. Rave and Vault require API extraction or scheduled exports. If your quality assurance or inspection readiness workflows depend on ad-hoc SQL, Oracle Clinical or Clinical One is the only option with that capability.

2. **Edit check language**: PL/SQL (OC) gives procedural power at the cost of DBA involvement in every check change. Rave's OpenRules and Vault's Expressions are simpler for data managers to write and version, but have less procedural flexibility for complex cross-study derivations.

3. **Amendment management**: In Oracle Clinical, a structural amendment (adding a question to a live DCM) requires database-level changes with impact analysis. In Rave and Vault, amendments are configuration changes within the study designer, with automated propagation tracking for subjects that already have data in the amended section.

4. **Inspection readiness**: All three platforms are 21 CFR Part 11 / Annex 11 compliant when configured correctly. The practical difference is where the audit trail lives: Oracle Clinical puts it in a queryable database table; Rave and Vault surface it through the application and API, which is sufficient for inspectors but limits ad-hoc SQL audit analysis.`,
};

async function main() {
  await db
    .insert(posts)
    .values(post)
    .onConflictDoUpdate({
      target: posts.slug,
      set: { title: post.title, content: post.content, excerpt: post.excerpt, updatedAt: new Date() },
    });
  console.log('Inserted:', post.slug);
}

main().catch(console.error);
